Product catalogue
Every compound held in the RSSE catalogue, with its CAS number, molecular formula and structure where available. Certificate of analysis issued per lot; quoted per enquiry.
1,407,499 products · 23459 pages
Products in this list

Tofacitinib Impurity N
IN STOCKRS-T041025
Tofacitinib Impurity 385
IN STOCKRS-T041026
Tofacitinib Impurity Q (1675248-19-7)
IN STOCKRS-T041027- Custom synthesis — structure on request
Tofacitinib Impurity A(Citrate)
IN STOCKRS-T041028 
(3S,4R) Tofacitinib Citrate
BACK ORDERRS-T041029
Tofacitinib Impurity C(Citrate)
IN STOCKRS-T041030
Tofacitinib Impurity 109
CUSTOM SYNTHESISRS-T041031
Tofacitinib Impurity 149
CUSTOM SYNTHESISRS-T041032
Tofacitinib Impurity Q
IN STOCKRS-T041033
Tofacitinib Impurity 317
IN STOCKRS-T041034
Tofacitinib Impurity M
IN STOCKRS-T041036
Tofacitinib Impurity L
IN STOCKRS-T041037
Tofacitinib Impurity R
CUSTOM SYNTHESISRS-T041038- Custom synthesis — structure on request
Tofacitinib Impurity 319
IN STOCKRS-T041039 
Tofacitinib Related Compound 26 HCl
IN STOCKRS-T041040
Tofacitinib Impurity 11
CUSTOM SYNTHESISRS-T041042
Tofacitinib Impurity 155(Hydrochloride)
IN STOCKRS-T041043![Chemical structure of 3-((3R,4R)-3-((7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-4-methylpiperidin-1-yl)-3-oxopropanenitrile](/structures/w4/RINVSZVUBKMZHU-PWSUYJOCSA-N.webp?v=11)

Tofacitinib Impurity 387
CUSTOM SYNTHESISRS-T041045
Tofacitinib Impurity N(Citrate)
IN STOCKRS-T041046
Tofacitinib Impurity M (1812890-23-5)
IN STOCKRS-T041047
Tofacitinib Impurity 133(Dihydrochloride)
IN STOCKRS-T041048
Tofacitinib Impurity 96
IN STOCKRS-T041050
Tofacitinib Impurity 389
BACK ORDERRS-T041051
Tofacitinib Impurity 320
IN STOCKRS-T041052
Tofacitinib Impurity 93
IN STOCKRS-T041053
Tofacitinib Impurity Y
CUSTOM SYNTHESISRS-T041054
Tofacitinib Formyl Impurity
IN STOCKRS-T041055![Chemical structure of Butyl 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanoate](/structures/w4/IQFJFTIXSPNYQX-ZBFHGGJFSA-N.webp?v=11)
![Chemical structure of 3-((3R,4R)-4-methyl-3-(methyl(7-tosyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile](/structures/w4/WZSHBRMUAGEXTG-XLIONFOSSA-N.webp?v=11)

Tofacitinib Impurity P
IN STOCKRS-T041058
Tofacitinib Impurity 390
IN STOCKRS-T041059
Tofacitinib Impurity 104
BACK ORDERRS-T041060
Tofacitinib Impurity 391
IN STOCKRS-T041061
Tofacitinib Impurity H
IN STOCKRS-T041062
Tofacitinib Impurity 392
CUSTOM SYNTHESISRS-T041063
Tofacitinib Impurity 21
IN STOCKRS-T041065- Custom synthesis — structure on request
Tofacitinib Impurity 393
IN STOCKRS-T041066 
Tofacitinib Impurity 110
BACK ORDERRS-T041067
Tofacitinib Impurity 98
IN STOCKRS-T041068![Chemical structure of 1,3-bis((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)propane-1,3-dione](/structures/w4/CFVCYPAWDKDZTI-VKGYTVAMSA-N.webp?v=11)

Tofacitinib Impurity 394
BACK ORDERRS-T041070
Tofacitinib Impurity 321
IN STOCKRS-T041071
Tofacitinib Impurity 396
IN STOCKRS-T041073
Tofacitinib Impurity 271
IN STOCKRS-T041074
Tofacitinib Impurity 397
CUSTOM SYNTHESISRS-T041075
Tofacitinib Impurity 398
IN STOCKRS-T041077![Chemical structure of 5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one Impurity](/structures/w4/NCIZQRMMYUHTDP-UHFFFAOYSA-N.webp?v=11)
5,7-dihydro-6H-pyrrolo [2,3-d] pyrimidin-6-one Impurity
CUSTOM SYNTHESISRS-T041078
Tofacitinib Impurity 146
IN STOCKRS-T041079
Tofacitinib Impurity 322
IN STOCKRS-T041080
Tofacitinib Impurity 264
IN STOCKRS-T041081
Tofacitinib Impurity 147
IN STOCKRS-T041082
Tofacitinib Impurity 399
IN STOCKRS-T041083
Tofacitinib Impurity 400
IN STOCKRS-T041084
Tofacitinib Impurity 45
CUSTOM SYNTHESISRS-T041085
Tofacitinib Impurity 401
IN STOCKRS-T041086
Tofacitinib Impurity 38
BACK ORDERRS-T041087
Tofacitinib Related Substance 1
IN STOCKRS-T041090
Tofacitinib Impurity 402
IN STOCKRS-T041091
Tofacitinib Citrate Mixure of Diastereomers
IN STOCKRS-T041092
1,407,499 products · 23459 pages